25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients

被引:12
|
作者
Nguyen, Nguyen N. [1 ]
Raju, Muppala N. P. [1 ]
da Graca, Briget [2 ]
Wang, Dapeng [1 ]
Mohamed, Nada A. [1 ]
Mutnal, Manohar B. [1 ]
Rao, Arundhati [1 ]
Bennett, Monica [2 ]
Gokingco, Matthew [1 ]
Huy Pham [1 ]
Mohammad, Amin A. [1 ]
机构
[1] Baylor Scott & White Cent Texas, Dept Pathol, Temple, TX 76508 USA
[2] Baylor Scott & White Res Inst, Dallas, TX USA
来源
PLOS ONE | 2022年 / 17卷 / 05期
关键词
VITAMIN-D; HEALTH;
D O I
10.1371/journal.pone.0268038
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Studies investigating the association between vitamin D and severity of COVID-19 have mixed results perhaps due to immunoassay assessment of total 25-hydroxyvitamin D (tD) (the sum of 25-hydroxyvitamin-D2 [25-OH-D2] and 25-hydroxyvitamin-D3 [25-OH-D3]). Liquid chromatography tandem mass spectrometry (LC-MS/MS) has high analytical specificity and sensitivity for 25-OH-D2 and 25-OH-D3, and thus enables a more accurate assessment of impact on COVID-19 outcomes. Methods We established reference intervals for 25-OH-D3 and tD using LC-MS/MS. 25-OH-D2, 25-OH-D3 and tD were quantitated for 88 COVID-19 positive and 122 COVID-19 negative specimens. Chi-square or Fisher's exact tests were used to test associations in binary variables. T-Tests or Wilcoxon rank sum tests were used for continuous variables. Cox proportional hazards were used to test associations between 25-OH-D3 or tD levels and length of stay (LOS). For mortality and ventilation, logistic regression models were used. Results COVID-19 patients with deficient (<20 ng/mL) levels of 25-OH-D3 had significantly longer LOS by 15.3 days. COVID-19 P patients with deficient (<20 ng/mL) and insufficient (<30 ng/mL) of tD had significantly longer LOS by 12.1 and 8.2 days, respectively. Patients with insufficient levels of tD had significantly longer LOS by 13.7 days. COVID-19 patients with deficient serum 25-OH-D3 levels had significantly increased risk-adjusted odds of in-hospital mortality (OR [95% CI]: 5.29 [1.53-18.24]); those with insufficient 25-OH-D3 had significantly increased risk for requiring ventilation during hospitalization was found at LCMS insufficient cutoff (OR [95% CI]: 2.75 [1.10-6.90]). Conclusions There is an inverse relationship of 25-hydroxyvitamin D levels and hospital LOS for COVID-19 patients. Vitamin D status is a predictor for severity of outcomes. LCMS results are useful for assessing the odds of mortality and the need for ventilation during hospitalization.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients
    Arunkumar Krishnan
    Laura Prichett
    Xueting Tao
    Saleh A Alqahtani
    James P Hamilton
    Esteban Mezey
    Alexandra T Strauss
    Ahyoung Kim
    James J Potter
    Po-Hung Chen
    Tinsay A Woreta
    World Journal of Gastroenterology, 2022, 28 (05) : 570 - 587
  • [32] Serum 25-hydroxyvitamin D predicts severity in Parkinson’s disease patients
    Ying Liu
    Ben-shu Zhang
    Neurological Sciences, 2014, 35 : 67 - 71
  • [33] Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients
    Krishnan, Arunkumar
    Prichett, Laura
    Tao, Xueting
    Alqahtani, Saleh A.
    Hamilton, James P.
    Mezey, Esteban
    Strauss, Alexandra T.
    Kim, Ahyoung
    Potter, James J.
    Chen, Po-Hung
    Woreta, Tinsay A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (05) : 570 - 587
  • [34] Vitamin D deficiency as a predictor of severity in patients with COVID-19 infection
    Teama, Mohammed Abd El Monem
    Abdelhakam, Dina A.
    Elmohamadi, Marwa A.
    Badr, Fatma Mohammed
    SCIENCE PROGRESS, 2021, 104 (03)
  • [35] Low Serum 25-hydroxyvitamin D (Vitamin D) Level Is Associated With Susceptibility to COVID-19, Severity, and Mortality: A Systematic Review and Meta-Analysis
    Akbar, Mohammad Rizki
    Wibowo, Arief
    Pranata, Raymond
    Setiabudiawan, Budi
    FRONTIERS IN NUTRITION, 2021, 8
  • [36] Circulating 25-hydroxyvitamin D, nasopharyngeal microbiota, and bronchiolitis severity
    Toivonen, Laura
    Hasegawa, Kohei
    Ajami, Nadim J.
    Celedon, Juan C.
    Mansbach, Jonathan M.
    Petrosino, Joseph F.
    Camargo, Carlos A., Jr.
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2018, 29 (08) : 877 - 880
  • [38] Fever as a Predictor of COVID-19 Outcomes in Hospitalized Patients
    Silva, Lucas Pereto
    Stocco, Rebecca Benicio
    Pereira, Marcos Roberto Curcio
    Koga, Julia Naomi
    Gomes, Isabela Pontarolo
    Carvalho, Joao Eduardo
    Beni, Giovana Muniz
    Negreiros, Paulo
    Baena, Cristina P.
    Marques, Gustavo Lenci
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [39] 25-Hydroxyvitamin D in Patients With Cognitive Decline
    Muratli, Sevilay
    Soyluk, Ozlem
    Tufan, Fatih
    JAMA NEUROLOGY, 2016, 73 (03) : 357 - 357
  • [40] Authors response to: Comment on "Grip strength as a predictor of disease severity in hospitalized COVID-19 patients"
    Kara, Ozgur
    Kara, Murat
    Akin, Mustafa Emre
    Ozcakar, Levent
    HEART & LUNG, 2023, 57 : 297 - 297